Challenges with risk mitigation in academic drug discovery: finding the best solution.
作者信息
Roy Anuradha
机构信息
a High Throughput Screening laboratory , University of Kansas , Lawrence , KS , USA.
出版信息
Expert Opin Drug Discov. 2019 Feb;14(2):95-100. doi: 10.1080/17460441.2019.1553952. Epub 2018 Dec 4.
Abstract
摘要
相似文献
1
Challenges with risk mitigation in academic drug discovery: finding the best solution.学术药物研发中风险缓解的挑战：寻找最佳解决方案。
Expert Opin Drug Discov. 2019 Feb;14(2):95-100. doi: 10.1080/17460441.2019.1553952. Epub 2018 Dec 4.
2
Risk mitigation in academic drug discovery.学术性药物研发中的风险缓解
Expert Opin Drug Discov. 2016;11(4):333-6. doi: 10.1517/17460441.2016.1152257. Epub 2016 Mar 3.
3
Open access high throughput drug discovery in the public domain: a Mount Everest in the making.公共领域的开放获取高通量药物发现：正在形成的珠穆朗玛峰。
Curr Pharm Biotechnol. 2010 Nov;11(7):764-78. doi: 10.2174/138920110792927757.
4
Have microfluidics delivered for drug discovery?微流控技术在药物研发中发挥作用了吗？
Expert Opin Drug Discov. 2016 Aug;11(8):745-8. doi: 10.1080/17460441.2016.1193485. Epub 2016 Jun 13.
5
Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.现代表型药物发现是一种可行的新古典制药策略。
J Med Chem. 2012 May 24;55(10):4527-38. doi: 10.1021/jm201649s. Epub 2012 Mar 23.
6
Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.大型制药公司筛选收藏：更多相同或独特的文库？阿斯利康-拜耳制药公司案。
Drug Discov Today. 2013 Oct;18(19-20):1014-24. doi: 10.1016/j.drudis.2012.10.011. Epub 2012 Nov 3.
7
Towards a hit for every target.靶向治疗的新突破。
Nat Rev Drug Discov. 2016 Jan;15(1):1-2. doi: 10.1038/nrd.2015.19. Epub 2015 Nov 20.
8
The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharma.SULSA检测开发基金：加速新生物学从学术界向制药行业的转化。
Drug Discov Today. 2017 Feb;22(2):199-203. doi: 10.1016/j.drudis.2016.09.028. Epub 2016 Oct 5.
9
10
Image-based profiling for drug discovery: due for a machine-learning upgrade?基于图像的药物发现分析：是否需要机器学习升级？
Nat Rev Drug Discov. 2021 Feb;20(2):145-159. doi: 10.1038/s41573-020-00117-w. Epub 2020 Dec 22.
引用本文的文献
1
A review for cell-based screening methods in drug discovery.药物发现中基于细胞的筛选方法综述。
Biophys Rep. 2021 Dec 31;7(6):504-516. doi: 10.52601/bpr.2021.210042.
2
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises.推进小分子SARS-CoV-2发现的资源与计算策略：从大流行中吸取的教训及为未来健康危机做准备
Comput Struct Biotechnol J. 2021;19:2537-2548. doi: 10.1016/j.csbj.2021.04.059. Epub 2021 Apr 26.
3
RNA-PROTACs: Degraders of RNA-Binding Proteins.RNA-PROTACs：RNA 结合蛋白降解剂。
Angew Chem Int Ed Engl. 2021 Feb 8;60(6):3163-3169. doi: 10.1002/anie.202012330. Epub 2020 Dec 10.
本文引用的文献
1
Top 20 translational researchers of 2017.2017年排名前20的转化医学研究人员。
Nat Biotechnol. 2018 Sep 6;36(9):798. doi: 10.1038/nbt.4237.
2
Early Probe and Drug Discovery in Academia: A Minireview.学术界的早期探索与药物发现：一篇综述短文
High Throughput. 2018 Feb 9;7(1):4. doi: 10.3390/ht7010004.
3
Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment.细胞类型和培养方法对体外肝脏系统功能的影响 - 用于肝毒性评估的细胞系统综述。
Toxicol In Vitro. 2018 Apr;48:262-275. doi: 10.1016/j.tiv.2018.01.023. Epub 2018 Feb 1.
4
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations.七年之痒：2017年的全面分析干扰化合物（PAINS）——效用与局限
ACS Chem Biol. 2018 Jan 19;13(1):36-44. doi: 10.1021/acschembio.7b00903. Epub 2017 Dec 26.
5
Current status and perspectives of patient-derived xenograft models in cancer research.患者来源异种移植模型在癌症研究中的现状与展望
J Hematol Oncol. 2017 May 12;10(1):106. doi: 10.1186/s13045-017-0470-7.
6
Academia-pharma partnerships for novel drug discovery: essential or nice to have?学术界与制药公司合作进行新药研发：是必不可少还是可有可无？
Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.
7
Tackling reproducibility in academic preclinical drug discovery.解决学术临床前药物发现中的可重复性问题。
Nat Rev Drug Discov. 2015 Nov;14(11):733-4. doi: 10.1038/nrd4737. Epub 2015 Sep 21.
8
Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.利用小分子探针推进生物学理解与治疗学发现
Cell. 2015 Jun 4;161(6):1252-65. doi: 10.1016/j.cell.2015.05.023.
9
Drug discoverers chart path to tackling data irreproducibility.药物研发人员绘制解决数据不可重复性问题的路径。
Nat Rev Drug Discov. 2014 Dec;13(12):875-6. doi: 10.1038/nrd4488.
10
A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies.一种基于细胞的高通量筛选方法，用于寻找治疗血红蛋白病的新型胎儿血红蛋白化学诱导剂。
PLoS One. 2014 Sep 16;9(9):e107006. doi: 10.1371/journal.pone.0107006. eCollection 2014.
Zotero 插件